Cargando…
Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
Rotaviruses (RV) are a major cause of severe gastroenteritis (GE) in children aged <5 y. For the first time in China, we assessed the efficacy of two oral doses of the human rotavirus vaccine (RIX4414) in infants during the first two years of life (113808/NCT01171963). Healthy infants aged 6–16 w...
Autores principales: | Li, Rong-cheng, Huang, Teng, Li, Yan-Ping, Luo, Dong, Tao, Junhui, Fu, Botao, Si, Guoai, Nong, Yi, Mo, Zhao-Jun, Liao, Xue-Yan, Luan, Ivy, Tang, Haiwen, Rathi, Niraj, Karkada, Naveen, Han, Htay Htay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181005/ https://www.ncbi.nlm.nih.gov/pubmed/24013441 http://dx.doi.org/10.4161/hv.26319 |
Ejemplares similares
-
Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
por: Li, Rong-cheng, et al.
Publicado: (2015) -
Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
por: Shin, Son Moon, et al.
Publicado: (2016) -
Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies
por: Li, Rong-Cheng, et al.
Publicado: (2013) -
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014) -
Pharmacoeconomic Spotlight on Rotavirus Vaccine RIX4414 (Rotarix™) in Developed Countries
por: Plosker, Greg L.
Publicado: (2012)